AMP-activated protein kinase (AMPK) is a cellular energy sensor whose activity responds to AMP concentration ([AMP]). An agent that activates AMPK in cells is 5-aminoimidazole-4-carboxamide-1-riboside (AICAriboside). Phosphorylated AICAriboside or AICAribotide (ZMP) is an AMP analog. It is generally assumed that ZMP accumulation does not alter [AMP].
Introduction
AMP-activated protein kinase (AMPK) and AMPK kinase (AMPKK) comprise a protein kinase cascade that has been highly conserved throughout evolution (10, 11) . The AMPK cascade acts as a cellular low fuel warning system (10) . Increases in AMP concentration ([AMP]) increase AMPK activity (7, 8) . Once activated AMPK functions to either conserve ATP or promote alternative methods of ATP generation. One way that AMPK stimulates ATP synthesis in the heart is by the phosphorylation of acetyl-CoA carboxylase (ACC). The phosphorylation inhibits ACC activity, which lowers malonyl-CoA formation. Lower malonylCoA, in turn, relieves the inhibition of carnitine palmitoyl transferase 1 (CPT1), the primary transporter and control point for fatty acyl-CoA entry into the mitochondrion. This results in an acceleration of the -oxidation of fatty acids and the generation of ATP.
Increased AMPK activity has been elicited by use of ischemia, hypoxia or metabolic inhibitors to alter cellular energetics and, hence, increase [AMP] . A pharmacological agent, 5-aminoimidazole-4-carboxamide-riboside (AICAriboside; Z-riboside), has been used to increase AMPK activity in a wide range of tissues and cell types including adipocytes (4) and skeletal muscle (17, 22) . AICAriboside does not directly activate AMPK. AICAriboside must be phosphorylated to the active agent 5-aminoimidazole-4-carboxamide-ribotide (AICAribotide; ZMP). ZMP accumulation in INS cells did not alter total AMP and ATP content but did increase AMPK activity (12) . Total AMP content was also unchanged in gastrocnemius muscles with ZMP formation accompanied by increased AMPK activity (22) . ZMP accumulation, however, decreased PCr in rat white quadriceps muscle (30). This raises the possibility that AICAriboside metabolism can reduce [PCr] . We have demonstrated that reductions in [PCr] increased cytosolic [AMP] in the heart (7, 8) .
ZMP, a structural analog of AMP, increases AMPK activity in vitro. The [ZMP] that affect AMPK activity are 50 times higher than the [AMP] required for increased AMPK activity.
In vitro measurements of the concentrations required for half-maximal (A 0.5 ) allosteric activity of AMPK have found the following: first, in the presence of 4 mM ATP the A 0.5 for AMP was 29 ± 14 µM while the A 0.5 for ZMP was 1.5 ± 0.6 mM (4); and, second, the A 0.5 for ZMP was 5 mM in the presence of 3 mM ATP (16) Metabolic Inhibitors-Addition of 0.3 mM 2-bromo-octanoic acid (BrO) (Aldrich, Milwaukee, WI) to the KH perfusate irreversibly inhibits the -oxidation of long chain fatty acids, which arise from endogenous triacylglycerol (26). Perfusion with 0.4 mM amino-oxyacetate (AOA) (SIGMA, St. Louis, MO), a reversible inhibitor of the malate-aspartate shuttle (25) , results in near complete inhibition of glucose oxidation (1). Figure 1 HPLC Analysis-Adenine nucleotides (ATP, ADP, AMP) and Z nucleotides (ZMP, ZDP, and ZTP) were measured in the perchloric acid extracts of freeze clamped hearts using methods described by Sabina et al (24) . The results are expressed as nmol × mg protein -1 . Protein was determined using the method of Lowry et al (21) . The isoform specific activity of AMPK in heart tissue was measured (8) after immunoprecipitation of the 2 subunits by anti-AMPK-2 antibodies coupled to protein A agarose beads (Upstate Biotechnology, Lake Placid, NY), activity was measured as the incorporation of 32 P into the SAMS peptide. Protein content was determined in the homogenization buffer and was adjusted to a content of 0.5 mg/ml prior to immunoprecipitation.
Study Design and Experimental Protocols to vary [AMP] and [ZMP]-

Measurement of AMP-Activated Protein
Measurement of the phosphorylation of Thr
172
of AMPK and Ser79 of ACCPhosphorylation was measured using western immunoblots as described by Frederich et al (8) .
The primary antibodies were anti-phospho-AMPK-polyclonal antibody (Thr Table 2A ).
Note that HPLC measured total AMP (and ADP) content did not change ( (Table 2B) . (Table 3) .
AMP-Activated Protein
There was a 6 fold increase in 2 isoform specific AMPK activity for the hearts perfused with 1 mM AICAriboside (Table 3) . This was consistent with the five fold increase in total activity measured for the 1 mM AICAriboside hearts. Note that the ZMP and AMPK activity can best be fit with a sigmoid equation. Modeling of the AMPK cascade predicted that the AMP to AMPK activity relationship should also be described by a sigmoid equation (12) . To date our measurements of the in vivo [AMP] and AMPK activity relationship (Fig, 4A) have been best fit with a hyperbola (8) . (Table 3) .
Discussion
The AMPK protein kinase cascade responds to [AMP] increases (10, 11 In the mouse heart we found a substantial increase in [ZMP] that was time and
[AICAriboside] dependent. The A 0.5 of ZMP for the phosphorylation of AMPK was 4.1 ± 0.6 mM, whereas, the A 0.5 for AMP was 5.5 ± 1.6 µM. Cytosolic ZMP binding to AMPK was, therefore, 800 fold less effective than AMP in promoting AMPK phosphorylation by AMPKK.
These results explain why AICAriboside does not increase AMPK activity in the isolated rat heart. The rat heart ZMP contents reported were equivalent to a 5'nucleotidase activity. The lack of appreciable formation of ZMP in the rat heart suggests the possibility that adenosine kinase activity may be too low relative to cytosolic 5'nucleotidase activity. Alternatively, the transport of AICAriboside, which occurs via the adenosine transporter (9), may be much lower in the rat heart. Low [ZMP] accumulation may not be limited to the rat heart. ZMP was not detectable in rabbit cardiomyoctes exposed to 500 µM AICAriboside (18) . In the heart the extent of ZMP formation is species dependent.
ZMP can be metabolized in several ways (28 (24) . The lack of ZMP metabolism to adenine nucleotides in our study of the mouse heart may result from the high [ZMP] achieved, which were well above 190 µM.
In One heart ( ) was perfused with KH + 1 mM AICAriboside continuously from time zero. Heart Groups: Glc = Krebs Henseleit (KH), Glc 600 = KH paced at 600 bpm, GA = KH without pyruvate plus amino-oxyacetate, GB = KH without pyruvate plus bromo-octanoate, GBA = KH without pyruvate plus bromo-octanoate and amino-oxyacetate and dobutamine. 
